OCD (Obsessive-Compulsive Disorder): Symptoms, Subtypes, and Treatment
Summary
Obsessive-compulsive disorder (OCD) is defined by obsessions — recurrent, intrusive, unwanted thoughts or images — and compulsions, the repetitive behaviors or mental acts done to relieve the anxiety they cause. About 1.2% of U.S. adults have OCD in a given year and 2.3% over a lifetime, with a mean age of onset near 19.5 years. First-line treatments are exposure and response prevention (ERP), a form of cognitive behavioral therapy, and SSRIs, often at higher doses than for depression.
Written by Gale Editorial · grounded in the cited clinical sources below · Updated 2026-07-07. How we write.
Talk to a clinician
Gale can match you with a clinician licensed in your state — the honest cost shown before you book.
Find care →What is obsessive-compulsive disorder?
Obsessive-compulsive disorder (OCD) is a condition marked by obsessions — recurrent, intrusive thoughts, images, or urges that cause marked distress — and compulsions, the repetitive behaviors or mental rituals performed to counteract the anxiety those obsessions produce 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure. The obsessions are unwanted and inconsistent with the person's sense of self (described clinically as egodystonic), which distinguishes OCD from ordinary preferences for order or cleanliness 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure. A diagnosis requires that the obsessions or compulsions are time-consuming — taking more than an hour per day — or cause clinically significant distress or impairment 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure.
OCD is common. Approximately 1.2% of U.S. adults had OCD in the past year, and the lifetime prevalence is 2.3% 2Ref 2National Institute of Mental Health (NIMH) (2024).Obsessive-Compulsive Disorder (OCD): Statistics.Past-year prevalence 1.2% and lifetime prevalence 2.3% among U.S. adults; sex-disaggregated past-year rates (females 1.8%, males 0.5%); serious impairment 50.6% and moderate impairment 34.8% among adults with OCD. It is not the casual "I'm so OCD about my desk" of everyday speech: the intrusive thoughts are distressing rather than satisfying, and the rituals are done to reduce fear, not for pleasure 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure5Ref 5National Institute of Mental Health (NIMH) (2024).Obsessive-Compulsive Disorder (OCD).Plain-language definition of OCD as uncontrollable recurring thoughts (obsessions) and repetitive behaviors (compulsions); symptoms are time-consuming and cause significant distress or interfere with daily life; onset usually between late childhood and young adulthood; treatments include psychotherapy and medication.
In the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), OCD is recognized as distinct from the anxiety disorders and grouped with several related conditions in a category often referred to as obsessive-compulsive and related disorders 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure.
How the obsession-compulsion cycle works
OCD tends to run in a self-reinforcing loop. An intrusive obsession — a fear of contamination, a violent image, a doubt about whether the stove was turned off — triggers intense anxiety. A compulsion (washing, checking, counting, silently repeating a phrase) briefly relieves that anxiety 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure5Ref 5National Institute of Mental Health (NIMH) (2024).Obsessive-Compulsive Disorder (OCD).Plain-language definition of OCD as uncontrollable recurring thoughts (obsessions) and repetitive behaviors (compulsions); symptoms are time-consuming and cause significant distress or interfere with daily life; onset usually between late childhood and young adulthood; treatments include psychotherapy and medication. The relief is temporary, and because it feels like the ritual "worked," the brain learns to reach for the compulsion again the next time the obsession appears. Over time the rituals grow and consume more of the day 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure.
Compulsions are not enjoyable and are not the same as habits or hobbies. They are performed to neutralize a feared outcome or to discharge distress, and people with OCD often recognize that the rituals are excessive even as they feel unable to stop 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure. Degree of insight varies from person to person.
Common subtypes and symptom themes
OCD looks different from person to person, but symptoms tend to cluster into recognizable themes. Common obsessions include 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure:
- Contamination — fear of being contaminated by germs, dirt, or bodily fluids, or of contaminating others
- Symmetry and exactness — a need for things to be balanced, even, or "just right"
- Pathologic doubt — recurrent worry about having done something incorrectly or incompletely (locking a door, turning off an appliance)
- Forbidden or taboo thoughts — intrusive aggressive, sexual, or religious thoughts, including fears of harming others or of being immoral (sometimes called scrupulosity)
Each theme is paired with characteristic compulsions: washing and cleaning rituals, checking, ordering and arranging, counting, reassurance-seeking, praying, or performing mental rituals to cancel out the thought 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure.
A point worth stating plainly: intrusive taboo thoughts — including thoughts about harm — are a symptom of OCD, not an intention. They are distressing precisely because they run against the person's values 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure. In a national survey of U.S. adults with OCD, the most commonly reported symptom types were checking (79.3%), hoarding (62.3%), and ordering (57.0%), with contamination symptoms reported by 25.7% 3Ref 3Ruscio AM, Stein DJ, Chiu WT, Kessler RC (2010).The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication.Mean age of onset 19.5 years with earlier onset in males (nearly a quarter before age 10); 28.2% of adults report lifetime obsessions or compulsions (subclinical); 90% lifetime comorbidity (anxiety disorders 75.8%, mood disorders 63.3%); most common symptom types among those with OCD (checking 79.3%, hoarding 62.3%, ordering 57.0%, contamination 25.7%). Hoarding is now classified as a separate disorder in DSM-5 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure.
How common is OCD, and who it affects
OCD affects 1.2% of U.S. adults in a given year and 2.3% over a lifetime 2Ref 2National Institute of Mental Health (NIMH) (2024).Obsessive-Compulsive Disorder (OCD): Statistics.Past-year prevalence 1.2% and lifetime prevalence 2.3% among U.S. adults; sex-disaggregated past-year rates (females 1.8%, males 0.5%); serious impairment 50.6% and moderate impairment 34.8% among adults with OCD. Among adults, past-year rates are higher in females (1.8%) than in males (0.5%) 2Ref 2National Institute of Mental Health (NIMH) (2024).Obsessive-Compulsive Disorder (OCD): Statistics.Past-year prevalence 1.2% and lifetime prevalence 2.3% among U.S. adults; sex-disaggregated past-year rates (females 1.8%, males 0.5%); serious impairment 50.6% and moderate impairment 34.8% among adults with OCD. The disorder tends to begin early: the mean age of onset is 19.5 years, and males have an earlier onset than females — nearly a quarter of affected males have onset before age 10 3Ref 3Ruscio AM, Stein DJ, Chiu WT, Kessler RC (2010).The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication.Mean age of onset 19.5 years with earlier onset in males (nearly a quarter before age 10); 28.2% of adults report lifetime obsessions or compulsions (subclinical); 90% lifetime comorbidity (anxiety disorders 75.8%, mood disorders 63.3%); most common symptom types among those with OCD (checking 79.3%, hoarding 62.3%, ordering 57.0%, contamination 25.7%).
Milder, subclinical obsessions and compulsions are far more widespread than the full disorder: 28.2% of adults reported experiencing obsessions or compulsions at some point in their lives, even though only a fraction meet full diagnostic criteria 3Ref 3Ruscio AM, Stein DJ, Chiu WT, Kessler RC (2010).The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication.Mean age of onset 19.5 years with earlier onset in males (nearly a quarter before age 10); 28.2% of adults report lifetime obsessions or compulsions (subclinical); 90% lifetime comorbidity (anxiety disorders 75.8%, mood disorders 63.3%); most common symptom types among those with OCD (checking 79.3%, hoarding 62.3%, ordering 57.0%, contamination 25.7%). OCD also rarely travels alone — an estimated 90% of people with lifetime OCD also meet criteria for another disorder, most often an anxiety disorder (75.8%) or a mood disorder such as depression (63.3%) 3Ref 3Ruscio AM, Stein DJ, Chiu WT, Kessler RC (2010).The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication.Mean age of onset 19.5 years with earlier onset in males (nearly a quarter before age 10); 28.2% of adults report lifetime obsessions or compulsions (subclinical); 90% lifetime comorbidity (anxiety disorders 75.8%, mood disorders 63.3%); most common symptom types among those with OCD (checking 79.3%, hoarding 62.3%, ordering 57.0%, contamination 25.7%).
OCD can be seriously disabling. Among adults with the disorder, roughly half (50.6%) had serious impairment, with another 34.8% experiencing moderate impairment 2Ref 2National Institute of Mental Health (NIMH) (2024).Obsessive-Compulsive Disorder (OCD): Statistics.Past-year prevalence 1.2% and lifetime prevalence 2.3% among U.S. adults; sex-disaggregated past-year rates (females 1.8%, males 0.5%); serious impairment 50.6% and moderate impairment 34.8% among adults with OCD.
Exposure and response prevention (ERP): the first-line therapy
The most effective psychotherapy for OCD is a specific form of cognitive behavioral therapy called exposure and response prevention (ERP), recommended as a first-line treatment 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure. In ERP, a person is gradually and deliberately exposed to the situations that trigger their obsessions — touching a "contaminated" surface, leaving an item slightly out of place — while resisting the urge to perform the usual compulsion. With repetition, the anxiety subsides on its own, and the brain relearns that the feared consequence does not follow and that the ritual is not needed 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure.
The evidence for ERP is strong. In a landmark randomized, placebo-controlled trial, intensive exposure and ritual prevention produced response rates of 62% (intent-to-treat) and 86% (among those who completed treatment), compared with 42%/48% for the medication clomipramine and 8%/10% for placebo 4Ref 4Foa EB, Liebowitz MR, Kozak MJ, et al. (2005).Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder.Response rates for exposure and ritual prevention (62% intent-to-treat, 86% completer), clomipramine (42%/48%), combination (70%/79%), and placebo (8%/10%); combination did not significantly improve on ERP alone; intensive exposure and ritual prevention may be superior to medication monotherapy. Adding medication to ERP did not significantly improve on ERP alone, and the authors concluded that intensive exposure and ritual prevention may be superior to medication monotherapy 4Ref 4Foa EB, Liebowitz MR, Kozak MJ, et al. (2005).Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder.Response rates for exposure and ritual prevention (62% intent-to-treat, 86% completer), clomipramine (42%/48%), combination (70%/79%), and placebo (8%/10%); combination did not significantly improve on ERP alone; intensive exposure and ritual prevention may be superior to medication monotherapy. ERP is demanding but time-limited.
Medication for OCD
Selective serotonin reuptake inhibitors (SSRIs) are the first-line medications for OCD and can be used on their own or combined with ERP 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure. Two features distinguish OCD treatment from depression treatment: OCD generally requires higher SSRI doses, and the response takes longer — usually at least four to six weeks to notice meaningful improvement, and sometimes ten weeks or more 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure.
Options in this class include fluoxetine, sertraline, fluvoxamine, paroxetine, citalopram, and escitalopram 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure. Clomipramine, a tricyclic antidepressant that also acts on serotonin, is effective but is generally reserved for people who have not responded to at least two adequate SSRI trials, because it carries more side effects 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure. People with severe symptoms or an inadequate response to first-line treatment are typically referred to a psychiatrist for further management 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure.
What to expect when seeking care
Evaluation begins with a clinical interview covering the specific obsessions and compulsions, how much time they consume, and how much they interfere with work, school, and relationships 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure. Clinicians commonly use the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) to measure symptom severity and to track change over the course of treatment 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure.
OCD symptoms usually begin between late childhood and young adulthood, though they can start at any age 5Ref 5National Institute of Mental Health (NIMH) (2024).Obsessive-Compulsive Disorder (OCD).Plain-language definition of OCD as uncontrollable recurring thoughts (obsessions) and repetitive behaviors (compulsions); symptoms are time-consuming and cause significant distress or interfere with daily life; onset usually between late childhood and young adulthood; treatments include psychotherapy and medication. Because ERP is a specialized skill, it helps to look specifically for a therapist trained in exposure and response prevention; SSRIs can be started by a primary care physician or psychiatrist 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure. Both first-line treatments have substantial evidence behind them, and combining them is a common approach for more severe presentations 1Ref 1Fenske JN, Petersen K (2015).Obsessive-Compulsive Disorder: Diagnosis and Management.Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure4Ref 4Foa EB, Liebowitz MR, Kozak MJ, et al. (2005).Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder.Response rates for exposure and ritual prevention (62% intent-to-treat, 86% completer), clomipramine (42%/48%), combination (70%/79%), and placebo (8%/10%); combination did not significantly improve on ERP alone; intensive exposure and ritual prevention may be superior to medication monotherapy.
Example practice profiles
Common questions
Talk to a clinician
Say what's going on in your own words. Gale finds a clinician licensed in your state and shows the real cost before you book.
Find care →When to seek care
- —Thoughts of suicide or self-harm — call or text 988 immediately
- —A genuine urge, plan, or intent to harm yourself or someone else (distinct from unwanted intrusive thoughts)
- —Obsessions or compulsions that consume hours each day and interfere with work, school, relationships, or self-care
- —Being unable to leave the house, eat, or sleep because of rituals or intrusive thoughts
- —New or worsening depression alongside OCD symptoms
- —Symptoms that have not improved after an adequate course of first-line treatment — a reason for referral to a psychiatrist
If you are having thoughts of suicide or self-harm, or feel you might act on an urge to harm yourself or someone else, call or text 988 (Suicide and Crisis Lifeline, available 24/7). Call 911 for an immediate safety emergency.
General health information, not medical advice. Synthetic demonstration content.
References
- 1.Fenske JN, Petersen K (2015). Obsessive-Compulsive Disorder: Diagnosis and Management. American Family Physician. PMID 26554283 ✓Definition of obsessions (egodystonic, intrusive) and compulsions; DSM-5 diagnostic threshold (time-consuming, >1 hour/day, or significant distress/impairment); reclassification distinct from anxiety disorders into obsessive-compulsive and related disorders; common obsession themes (contamination, symmetry/exactness, pathologic doubt, forbidden/taboo thoughts) and compulsions; ERP and SSRIs as first-line; higher SSRI doses and longer (4-6 to 10+ weeks) response time; clomipramine reserved after two SSRI trials; referral of severe/refractory cases; Y-BOCS as severity measure
- 2.National Institute of Mental Health (NIMH) (2024). Obsessive-Compulsive Disorder (OCD): Statistics. NIMH. link ✓Past-year prevalence 1.2% and lifetime prevalence 2.3% among U.S. adults; sex-disaggregated past-year rates (females 1.8%, males 0.5%); serious impairment 50.6% and moderate impairment 34.8% among adults with OCD
- 3.Ruscio AM, Stein DJ, Chiu WT, Kessler RC (2010). The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Molecular Psychiatry. doi:10.1038/mp.2008.94 ✓Mean age of onset 19.5 years with earlier onset in males (nearly a quarter before age 10); 28.2% of adults report lifetime obsessions or compulsions (subclinical); 90% lifetime comorbidity (anxiety disorders 75.8%, mood disorders 63.3%); most common symptom types among those with OCD (checking 79.3%, hoarding 62.3%, ordering 57.0%, contamination 25.7%)
- 4.Foa EB, Liebowitz MR, Kozak MJ, et al. (2005). Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder. American Journal of Psychiatry. doi:10.1176/appi.ajp.162.1.151 ✓Response rates for exposure and ritual prevention (62% intent-to-treat, 86% completer), clomipramine (42%/48%), combination (70%/79%), and placebo (8%/10%); combination did not significantly improve on ERP alone; intensive exposure and ritual prevention may be superior to medication monotherapy
- 5.National Institute of Mental Health (NIMH) (2024). Obsessive-Compulsive Disorder (OCD). NIMH. link ✓Plain-language definition of OCD as uncontrollable recurring thoughts (obsessions) and repetitive behaviors (compulsions); symptoms are time-consuming and cause significant distress or interfere with daily life; onset usually between late childhood and young adulthood; treatments include psychotherapy and medication
https://www.gale.care/conditions/ocd · 5 sources. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy